Stock Scorecard
Stock Summary for Absci Corp (ABSI) - $10.35 as of 9/25/2026 12:00:47 PM EST
Total Score
7 out of 30
Safety Score
29 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ABSI
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ABSI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ABSI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ABSI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ABSI (29 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Financial Details for ABSI
Company Overview |
|
|---|---|
| Ticker | ABSI |
| Company Name | Absci Corp |
| Country | N/A |
| Description | Absci Corp (ABSI) is a cutting-edge biotechnology company that utilizes a proprietary AI-driven platform to revolutionize drug discovery and development. By facilitating the rapid generation of high-quality proteins and therapeutic candidates, Absci effectively shortens development timelines and lowers associated costs, establishing itself as a key innovator within the biopharmaceutical sector. The company's robust pipeline, complemented by strategic partnerships, underscores its commitment to advancing next-generation therapies that address critical medical needs and improve patient outcomes. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 11/11/2026 |
Stock Price History |
|
| Last Day Price | 10.35 |
| Price 4 Years Ago | 2.10 |
| Last Day Price Updated | 9/25/2026 12:00:47 PM EST |
| Last Day Volume | 3,388,022 |
| Average Daily Volume | 3,470,661 |
| 52-Week High | 12.05 |
| 52-Week Low | 2.24 |
| Last Price to 52 Week Low | 362.05% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 27.95 |
| Sector PE | 63.75 |
| 5-Year Average PE | -8.38 |
| Free Cash Flow Ratio | 16.43 |
| Industry Free Cash Flow Ratio | 35.85 |
| Sector Free Cash Flow Ratio | 33.68 |
| Current Ratio Most Recent Quarter | 10.63 |
| Total Cash Per Share | 0.63 |
| Book Value Per Share Most Recent Quarter | 1.44 |
| Price to Book Ratio | 6.85 |
| Industry Price to Book Ratio | 12.84 |
| Sector Price to Book Ratio | 9.79 |
| Price to Sales Ratio Twelve Trailing Months | 1,177.44 |
| Industry Price to Sales Ratio Twelve Trailing Months | 58.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 41.16 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 171,614,000 |
| Market Capitalization | 1,776,204,900 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -11.71% |
| Reported EPS 12 Trailing Months | -0.86 |
| Reported EPS Past Year | -0.40 |
| Reported EPS Prior Year | -0.88 |
| Net Income Twelve Trailing Months | -121,077,000 |
| Net Income Past Year | -115,183,000 |
| Net Income Prior Year | -103,106,000 |
| Quarterly Revenue Growth YOY | -46.40% |
| 5-Year Revenue Growth | -10.14% |
| Operating Margin Twelve Trailing Months | -10,742.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 107,865,000 |
| Total Cash Past Year | 20,025,000 |
| Total Cash Prior Year | 41,213,000 |
| Net Cash Position Most Recent Quarter | 107,800,000 |
| Net Cash Position Past Year | 18,768,000 |
| Long Term Debt Past Year | 1,257,000 |
| Long Term Debt Prior Year | 1,257,000 |
| Total Debt Most Recent Quarter | 65,000 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 189,449,000 |
| Total Stockholder Equity Prior Year | 179,133,000 |
| Total Stockholder Equity Most Recent Quarter | 246,131,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -109,180,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.64 |
| Free Cash Flow Past Year | -94,032,000 |
| Free Cash Flow Prior Year | -72,806,000 |
Options |
|
| Put/Call Ratio | 2.52 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.21 |
| MACD Signal | 0.01 |
| 20-Day Bollinger Lower Band | 4.89 |
| 20-Day Bollinger Middle Band | 8.36 |
| 20-Day Bollinger Upper Band | 11.83 |
| Beta | 2.44 |
| RSI | 68.23 |
| 50-Day SMA | 5.26 |
| 150-Day SMA | 4.15 |
| 200-Day SMA | 3.60 |
System |
|
| Modified | 9/24/2026 4:20:38 PM EST |